Publications

2005 Articles

Barton JJS, Greenzang C, Hefter R, Edelman J, Manoach DS. Switching, plasticity and prediction in a saccadic task-switch paradigm. Experimental Brain Research, 1-12, 2005. View Abstract

Barton JJS, Lindgren KA, Goff DC, Manoach DS. What is perseverated in schizophrenia? Evidence of abnormal response plasticity in the saccadic system. Journal of Abnormal Psychology, 114(1): 75-84, 2005. View Abstract

Barton JJS, Raoof M, Jameel O, Manoach DS: Task-switching with antisaccades versus no-go trials: a comparison of inter-trial effects. Experimental Brain Research, 1-6, 2005.  View Abstract

Buchanan RW, Davis M, Goff DC, Green MF, Keefe RS, Leon AC, Nuechterlein KH, Laughren T, Levin R, Stover E, Fenton W, Marder SR. A summary of the FDA-NIMH MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schiz Bull Bull. 2005; 31(1): 5-19.  View Abstract

Cather C. Functional Cognitive Behavioral Therapy: a brief individual treatment for functional impairments resulting from psychotic symptoms in schizophrenia. Canadian Journal of Psychiatry. 2005; 50: 258-63.  View Abstract

Cather C, Penn D, Otto MW, Yovel I, Mueser K T, Goff DC. A pilot study of functional cognitive behavioral therapy for schizophrenia. Schizophrenia Research. 2005; 74: 201-9.  View Abstract

Ditman T, Kuperberg GR.A source monitoring account of auditory verbal hallucinations in schizophrenia. Harvard Review of Psychiatry; 2005; 13:280-99.  View Abstract

Evins AE, Cather C, Deckersbach T, Freudenreich O, Culhane MA, Olm-Shipman CM, Henderson DC, Schoenfeld DA, Goff DC, Rigotti NA. A double blind placebo controlled trial of bupropion SR for smoking cessation in schizophrenia. Journal of Clinical Psychopharmacology. 2005;25:1-8.  View Abstract

Evins AE, Deckersbach T, Cather C, Freudenreich O, Culhane MA, Henderson DC, Green MF, Schoenfeld DA, Rigotti NA, Goff DC. Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. J Clin Psychiatry. 2005;66(9):1184-90.  View Abstract

Freudenreich O, Herz L, Deckersbach T, Evins AE, Henderson DC, Cather C, Goff DC. Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial. Psychopharmacology. 2005;181(2):358-63.  View Abstract

Goff DC. Pharmacological implications of neurobiological models of schizophrenia. Harvard Review of Psychiatry. 2005; 31: 352-9.  View Abstract

Goff DC, Cather C, Evins AE, Henderson DC, Freudenreich O, Copeland PM, Bierer M, Duckworth K, Sacks F. Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. Journal of Clinical Psychiatry 2005; 66:183-94.  View Abstract

Goff DC, Herz L, Posever T, Shih V, Tsai G, Henderson DC, Freudenreich O, Evins AE, Yovel I, Zhang H, Schoenfeld D. A six-month, placebo-controlled trial of D-cycloserine augmentation of conventional antipsychotics in schizophrenia patients. Psychopharmacology. 2005; 179(1): 144-50.  View Abstract

Goff DC, Sullivan LM, McEvoy JP, Meyer JM, Nasrallah HA, Daumit GL, Lamberti S, D’Agostino RB, Stroup TS, Davis S, Lieberman JA. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005; 80: 45-53.  View Abstract

Gottlieb JD, Pryzgoda J, Schuldberg D, Neal AC. Generalization of skills through the addition of individualized coaching: Development and evaluation of a Social Skills Training Program in a rural setting. Cognitive and Behavioral Practice. 2005; 12(3): 324-38.

Hefter RL, Manoach DS, Barton JJS: Perception of facial expression and facial identity in social developmental disorders. Neurology. 2005; 65(10): 1620-5.  View Abstract

Henderson DC. The Art of Practice: What should physicians know about the metabolic effects of second-generation antipsychotic medications? Massachusetts General Hospital Curbside Consultant. 2005; 3-(6) 3-4.

Henderson DC. Metabolic differences of antipsychotics among the Races. CNS Spectrum. 2005; 10 suppl 2: 13-20.  View Abstract

Henderson DC. Schizophrenia and comorbid metabolic disorders. J Clin Psychiatry. 2005; 66 Suppl 6:11-20.  View Abstract

Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins AE, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley TB, Schoenfeld D, Goff DC. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Archives of General Psychiatry. 2005; 62(1): 19-28.  View Abstract

Henderson DC, Copeland PM, Daley TB, Borba CP, Cather C, Nguyen DD, Louie PM, Evins AE, Freudenreich O, Hayden D, Goff DC. A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain. Am J Psychiatry. 2005; 162(5): 954-62.  View Abstract

Henderson DC, Koul P, Namey L, Daley TB, Nguyen DD, Louie PM, Goff DC: Modafinil-associated weight loss in a clozapine-treated schizoaffective disorder patient. 2005; Ann Clin Psych. 2005; 17:95-97.  View Abstract

Henderson DC, Mollica RF, Tor S, Lavelle J, Culhane MA, Hayden D. Building primary care practitioners' attitudes and confidence in mental health skills in a post-conflict society: a Cambodian example. J Nerv Ment Dis 2005; 193(8): 551-9.  View Abstract

Henderson DC, Nguyen DD, Copeland PM, Hayden DL, Borba CP, Louie PM, Freudenreich O, Evins AE, Cather C, Goff DC. Clozapine, Diabetes Mellitus, Hyperlipidemia, and Cardiovascular Risks and Mortality: Results of a 10-Year Naturalistic Study. J Clin Psychiatry 2005; 66(9):1116-21.  View Abstract

Holt DJ, Bachus SE, Hyde TM, Wittie M, Herman MM, Vangel M, Saper CB, and Kleinman JE. Reduced density of cholinergic interneurons in the ventral striatum in schizophrenia: an in situ hybridization study. Biological Psychiatry. 2005; 58:408-16.  View Abstract

Holt DJ, Weiss AP, Rauch SL, Wright CI, Zalesak M, Goff DC, Ditman T, Welsh RC, Heckers S. Sustained activation of the hippocampus in response to fearful faces in schizophrenia. Biological Psychiatry 2005;57:1011-1019.  View Abstract

Large CH, Webster EL, Goff DC. The potential role of lamotrigine in schizophrenia. Psychopharmacol. 2005; 181: 415-36.  View Abstract

Manoach DS, White N, Lindgren KA, Heckers S, Coleman MJ, Dubal S, Goff DC, Holzman PS. Intact hemispheric specialization for spatial and shape working memory in schizophrenia. Schizophrenia Research. 2005; 78(1): 1-12.  View Abstract

McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, Meltzer HY, Hsiao J, Stroup TS, Lieberman JA. Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Effectiveness of Interventions Trial (CATIE) schizophrenia trial and comparisons with national estimates from NHANES III. Schiz Res. 2005; 80(1): 19-32.  View Abstract

Merrill DN, Dec GW, Goff DC. Adverse Cardiac Effects Associated with Clozapine. Journal of Clinical Psychopharmacology. 2005; 25: 32-41. 

Meyer JM, Nasrallah HA, McEvoy JP, Goff DC, Davis SM, Chakos M, Patel JK, Keefe R, Stroup TS, Lieberman JA. The clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial: Clinical comparisons of subgroups with and without the metabolic syndrome. Schiz Res. 2005; 80(1):9-18.  View Abstract

Morrow EM, Falk WE. Pharmacotherapy of anxiety in the elderly. Geriatrics and Aging, Volume 8, No. 5, May 2005, 37-41.

Morrow EM, Furukawa T, Raviola E, Cepko CL. Synaptogenesis and outer segment formation are perturbed in the neural retina of Crx mutant mice. BMC Neuroscience, 6, 5, January 2005. View Abstract

O’Neil SE, Cather C, Fishel AK, Kafka M. “Not Knowing If I Was a Pedophile …”—Diagnostic Questions and Treatment Strategies in a Case of OCD. Harvard Review of Psychiatry. 2005; 13: 186-96.  View Abstract

Ongur D, Goff DC. Obsessive-compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication status. Schizophrenia Research. 2005; 75(2-3):349-62.  View Abstract

Ongur D, Zalesak M. Weiss AP, Ditman T, Titone D, Heckers S. Hippocampal activation during processing of previously seen visual pairs. Psychiatry Research-Neuroimaging 2005; 139:191-98.  View Abstract

Polli FE, Barton JJS, Cain MS, Thakkar KN, Rauch SL, Manoach DS. Rostral and dorsal anterior cingulate cortex make dissociable contributions during antisaccade error commission. Proceedings of the National Academy of Sciences. 2005; 102: 15700-5.  View Abstract

Roffman JL, Marci CD, Glick DM, Dougherty DD, Rauch SL (2005). Neuroimaging and the functional neuroanatomy of psychotherapy. Psychological Medicine, 35(10), 1385-1398.  View Abstract

Weiss AP. Measuring the impact of medical research: moving from outputs to outcomes. American Journal of Psychiatry. 2005; 164(2): 206-14. View Abstract

Weiss AP, DeWitt I, Goff DC, Ditman T, Heckers S. Anterior and posterior hippocampal volumes in schizophrenia. Schizophrenia Research. 2005; 73:103-112.  View Abstract

Yurgelun-Todd DA, Coyle JT, Gruber SA, Renshaw F, Silveri MM, Amico E, Cohen B, Goff DC. Functional magnetic resonance imaging of studies of schizophrenic patients during word production: effects of D-cycloserine. Psychiatry Res 2005; 138:23-31.  View Abstract

Top of Page